{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T09:38:24Z","timestamp":1780738704957,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/s00436-013-3414-3","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T06:37:53Z","timestamp":1365489473000},"page":"2487-2494","source":"Crossref","is-referenced-by-count":8,"title":["Molecular cloning, sequencing, and biological characterization of GRA4 gene of Toxoplasma gondii"],"prefix":"10.1007","volume":"112","author":[{"given":"Hira","family":"Ram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. R.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. S.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"3414_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(03)00377-6","volume":"266","author":"MB Benita","year":"2003","unstructured":"Benita MB, Laloup M, Versteyhe S, Dewit J, Braekeleer JD, Jongert E, Borchard G (2003) Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization and preliminary in vivo studies. Int J Pharm 266:17\u201327","journal-title":"Int J Pharm"},{"key":"3414_CR2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1286-4579(03)00048-0","volume":"5","author":"GM Bhopale","year":"2003","unstructured":"Bhopale GM (2003) Development of a vaccine for toxoplasmosis: current status. Microbes Infect 5:457\u2013462","journal-title":"Microbes Infect"},{"key":"3414_CR3","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1128\/IAI.61.5.2082-2088.1993","volume":"61","author":"I Bourguin","year":"1993","unstructured":"Bourguin I, Chardes T, Bout D (1993) Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhance protective and cell mediated immunity in C57BL\/6 mice. Infect Immun 61:2082\u20132088","journal-title":"Infect Immun"},{"key":"3414_CR4","first-page":"419","volume":"85","author":"CR Brown","year":"1995","unstructured":"Brown CR (1995) Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 85:419\u2013428","journal-title":"Immunology"},{"key":"3414_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0007-1935(89)90053-5","volume":"145","author":"D Buxton","year":"1989","unstructured":"Buxton D, Uggala A, Lovgren K, Thomson K, Kunden A, Morein B, Blewett DA (1989) Trial of a novel ISCOM vaccine in pregnant sheep. Br Vet J 145:451\u2013457","journal-title":"Br Vet J"},{"key":"3414_CR6","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","volume":"64","author":"N Debard","year":"1996","unstructured":"Debard N, Bujoni-Gatel D, Bout D (1996) Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect Immun 64:2158\u20132166","journal-title":"Infect Immun"},{"key":"3414_CR7","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/S0264-410X(00)00035-9","volume":"18","author":"B Desolme","year":"2000","unstructured":"Desolme B, Mevelec MN, Buzoni-Gatel D, Bout D (2000) Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18:2512\u20132521","journal-title":"Vaccine"},{"key":"3414_CR8","author":"H Dlugonska","year":"2008","unstructured":"Dlugonska H (2008) Toxoplasma Rhoptries: unique secretary organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotech. doi: 10.1155\/2008\/632424","journal-title":"J Biomed Biotech"},{"key":"3414_CR9","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","volume":"146","author":"RT Gazzinelli","year":"1991","unstructured":"Gazzinelli RT, Hakim FT, Hieny S, Shearer GM, Sher A (1991) Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J Immunol 146:286\u2013292","journal-title":"J Immunol"},{"key":"3414_CR10","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.4049\/jimmunol.153.6.2533","volume":"153","author":"RT Gazzinelli","year":"1994","unstructured":"Gazzinelli RT, Wysocka M, Denkers EY, Hieny S, Caspar P, Trichieri G, Sher A (1994) Parasite-induced IL-12 stimulates early IFN-\u03b3 synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 153:2533\u20132543","journal-title":"J Immunol"},{"key":"3414_CR11","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.68.9.4948-4953.2000","volume":"68","author":"M Haumont","year":"2000","unstructured":"Haumont M, Delhaye L, Garcia L, Juardo M, Mazzu P, Daminet V, Verlant V, Bollen A, Biemans R, Jacqent A (2000) Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in guinea pig model. Infect Immun 68:4948\u20134953","journal-title":"Infect Immun"},{"key":"3414_CR12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00436-006-0341-6","volume":"100","author":"Z Huaiyu","year":"2007","unstructured":"Huaiyu Z, Qinmin G, Qunli Z, Jiaqin Z, Hua C, Yi L, Shenyi H (2007) Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol Res 100:829\u2013835","journal-title":"Parasitol Res"},{"key":"3414_CR13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.exppara.2007.10.002","volume":"118","author":"M Igarashi","year":"2008","unstructured":"Igarashi M, Kano F, Tamekuni K, Machado RZ, Navarro IT, Vidotto O, Vidotto MC, Garcia JL (2008) Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB\/c mice. Exp Parasitol 118:386\u2013392","journal-title":"Exp Parasitol"},{"key":"3414_CR14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1286-4579(03)00148-5","volume":"5","author":"M Johnson","year":"2003","unstructured":"Johnson M, Broady K, Angelici MC, Johnson A (2003) The relationship between nucleoside triphosphate hydrolase (NTPase) isoform and Toxoplasma strain virulence in rat and human toxoplasmosis. Microbes Infect 5:797\u2013806","journal-title":"Microbes Infect"},{"key":"3414_CR15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","volume":"104","author":"E Jongert","year":"2009","unstructured":"Jongert E, Roberts CW, Gargano N, Forster-Wald E, Petersen E (2009) Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz Rio de Janeiro 104:252\u2013266","journal-title":"Mem Inst Oswaldo Cruz Rio de Janeiro"},{"key":"3414_CR16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00436-011-2296-5","volume":"109","author":"WS Li","year":"2011","unstructured":"Li WS, Chen QX, Ye JX, Xie ZX, Chen J, Zhang LF (2011) Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune response. Parasitol Res 109:637\u2013644","journal-title":"Parasitol Res"},{"key":"3414_CR17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00436-010-1742-0","volume":"106","author":"MM Liu","year":"2010","unstructured":"Liu MM, Yuan ZG, Peng GH, Zhou DH, He XH, Yan C, Yin CC, He Y, Lin RQ, Song HQ, Zhu XQ (2010) Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis. Parasitol Res 106:1079\u20131084","journal-title":"Parasitol Res"},{"key":"3414_CR18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0304-4017(94)00670-8","volume":"56","author":"A Lunden","year":"1995","unstructured":"Lunden A (1995) Immune response in sheep after immunization with Toxoplasma gondii antigen incorporated into ISCOMS. Vet Parasitol 56:23\u201335","journal-title":"Vet Parasitol"},{"key":"3414_CR19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","volume":"11","author":"V Martin","year":"2004","unstructured":"Martin V, Supanitsky A, Echevrria PC, Litwin S, Tanos T, De Roodt AR, Guarnera EA, Angel SO (2004) Recombinant GRA4 and ROP2 protein combined with alum or the GRA4 gene provide partial protection in chronic murine models of toxoplasmosis. Clin Diag Lab Immunol 11:704\u2013710","journal-title":"Clin Diag Lab Immunol"},{"key":"3414_CR20","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.vaccine.2005.04.025","volume":"23","author":"MN Mevelec","year":"2005","unstructured":"Mevelec MN, Bout D, Desolme B, Marchand H, Magne R, Bruneel O, Buzoni-Gatel D (2005) Evaluation of protective effect of DNA vaccination with gene encoding GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronic and congenital toxoplasmosis in mice. Vaccine 23:4489\u20134499","journal-title":"Vaccine"},{"key":"3414_CR21","doi-asserted-by":"crossref","first-page":"45259","DOI":"10.1074\/jbc.M205517200","volume":"227","author":"MT Morris","year":"2002","unstructured":"Morris MT, Coppin A, Tomavo S, Carruthers VB (2002) Functional analysis of Toxoplasma gondii protease inhibitor 1. J Biol Chem 227:45259\u201345266","journal-title":"J Biol Chem"},{"key":"3414_CR22","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.3347\/kjp.2009.47.S.S29","volume":"47","author":"HW Nam","year":"2009","unstructured":"Nam HW (2009) GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane. Korean J Parasitol 47:S29\u2013S37","journal-title":"Korean J Parasitol"},{"key":"3414_CR23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1991.tb08150.x","volume":"84","author":"SJ Parker","year":"1991","unstructured":"Parker SJ, Roberts CW, Alexander J (1991) CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin Exp Immunol 84:207\u2013212","journal-title":"Clin Exp Immunol"},{"key":"3414_CR24","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","volume":"16","author":"E Petersen","year":"1998","unstructured":"Petersen E, Nielsen HV, Christiansen L, Spenter J (1998) Immunization with E. coli produced recombinant Toxoplasma gondii SAG1 with alum as adjuvant protects mice against lethal infection with Toxoplasma gondii. Vaccine 16:1283\u20131289","journal-title":"Vaccine"},{"key":"3414_CR25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0166-6851(02)00045-2","volume":"121","author":"V Pszenny","year":"2002","unstructured":"Pszenny V, Ledesma BE, Matrajt M, Duschak VG, Bontempi EJ, Dubremetz JF, Angel SO (2002) Subcellular localization and post-secretory targeting of TgPI, a serine proteinase inhibitor from Toxoplasma gondii. Mol Biochem Parasitol 121:283\u2013286","journal-title":"Mol Biochem Parasitol"},{"key":"3414_CR26","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","volume":"240","author":"Y Suzuki","year":"1988","unstructured":"Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516\u2013518","journal-title":"Science"},{"key":"3414_CR27","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","volume":"76","author":"H Towbin","year":"1979","unstructured":"Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from acrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350\u20134354","journal-title":"Proc Natl Acad Sci USA"},{"key":"3414_CR28","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/IAI.68.2.969-972.2000","volume":"68","author":"F Velge-Roussel","year":"2000","unstructured":"Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT (2000) Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect Immun 68:969\u2013972","journal-title":"Infect Immun"},{"key":"3414_CR29","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00436-012-3047-y","volume":"111","author":"XN Wu","year":"2012","unstructured":"Wu XN, Lin J, Lin X, Chen J, Chen ZL, Lin JY (2012) Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice. Parasitol Res 111:2001\u20132009","journal-title":"Parasitol Res"},{"key":"3414_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1756-3305-4-213","volume":"4","author":"Z Xi-Meng Sun Jun","year":"2011","unstructured":"Xi-Meng Sun Jun Z, Elashram Saeed AA, Wen-Chao Y, Xian-Yong L, Suo X, Heng W, Qi-Jun C (2011) DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice. Parasit Vectors 4:213","journal-title":"Parasit Vectors"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-013-3414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-013-3414-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-013-3414-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T22:06:56Z","timestamp":1688162816000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-013-3414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1007\/s00436-013-3414-3","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}